U.S. FDA approves first nasal spray for allergic reactions

ARS Pharmaceuticals

09/08/2024 16:29

Aug 9 (Reuters) - The U.S. Food and Drug Administration
said on Friday that it has approved ARS Pharmaceuticals'
 SPRY.O  nasal spray as the first needle-free emergency
treatment for allergic reactions.

 (Reporting by Sriparna Roy in Bengaluru; Editing by Shailesh
Kuber)
 ((Sriparna.Roy@thomsonreuters.com;))